Odyssey of trefoil factors in cancer: Diagnostic and therapeutic implications.
Animals
Antineoplastic Agents
/ pharmacology
Biomarkers, Tumor
/ agonists
Cell Transformation, Neoplastic
/ drug effects
Disease Models, Animal
Disease Progression
Disease-Free Survival
Epigenesis, Genetic
/ drug effects
Gene Expression Regulation, Neoplastic
/ drug effects
Humans
Mice
Mucous Membrane
/ metabolism
Neoplasm Staging
Neoplasms
/ drug therapy
Oncogene Proteins
/ analysis
Prognosis
Protein Domains
Trefoil Factors
/ agonists
Tumor Suppressor Proteins
/ agonists
Biomarker
Cancer
Cancer subtype
Cell signaling
Mouse model
Precancerous lesion
TFF1
TFF2
TFF3
Trefoil factor
Journal
Biochimica et biophysica acta. Reviews on cancer
ISSN: 1879-2561
Titre abrégé: Biochim Biophys Acta Rev Cancer
Pays: Netherlands
ID NLM: 9806362
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
received:
10
02
2020
revised:
01
04
2020
accepted:
01
04
2020
pubmed:
17
4
2020
medline:
22
7
2020
entrez:
17
4
2020
Statut:
ppublish
Résumé
Trefoil factors 1, 2, and 3 (TFFs) are a family of small secretory molecules involved in the protection and repair of the gastrointestinal tract (GI). TFFs maintain and restore epithelial structural integrity via transducing key signaling pathways for epithelial cell migration, proliferation, and invasion. In recent years, TFFs have emerged as key players in the pathogenesis of multiple diseases, especially cancer. Initially recognized as tumor suppressors, emerging evidence demonstrates their key role in tumor progression and metastasis, extending their actions beyond protection. However, to date, a comprehensive understanding of TFFs' mechanism of action in tumor initiation, progression and metastasis remains obscure. The present review discusses the structural, functional and mechanistic implications of all three TFF family members in tumor progression and metastasis. Also, we have garnered information from studies on their structure and expression status in different organs, along with lessons from their specific knockout in mouse models. In addition, we highlight the emerging potential of using TFFs as a biomarker to stratify tumors for better therapeutic intervention.
Identifiants
pubmed: 32298747
pii: S0304-419X(20)30026-3
doi: 10.1016/j.bbcan.2020.188362
pii:
doi:
Substances chimiques
Antineoplastic Agents
0
Biomarkers, Tumor
0
Oncogene Proteins
0
Trefoil Factors
0
Tumor Suppressor Proteins
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
188362Subventions
Organisme : NCI NIH HHS
ID : R44 CA224619
Pays : United States
Organisme : NCI NIH HHS
ID : R43 CA235984
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA200466
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA210240
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA217798
Pays : United States
Informations de copyright
Copyright © 2020. Published by Elsevier B.V.